of in situ canine intrinsic cardiac neuronal activity by nicotinic, muscarinic, and p-adrenergic agonists. Am. J. Physiol.
Comp. Physiol. 34): R659-R669, 1993.-To investigate whether microvolumes (~10 ~1) of nicotinic, muscarinic, and ,8-adrenergic agonists can modify intrinsic cardiac neuronal activity, nicotine, l,l-dimethyl-4-phenylpiperazinium iodide (DMPP), bethanechol chloride, and isoproterenol were separately administered adjacent to spontaneously active in situ epicardial neurons in 15 anesthetized dogs. Neuronal activity generated by 46 of 63 neurons was modified by these neurochemicals, with about half of the neurons affected by more than one agent. In association with these neuronal responses, cardiodynamic responses were elicited in 17 instances. When cardiac augmentation was elicited, it persisted after the administration of atropine but not of timolol. After cardiac decentralization, 40% of previously active neurons were still modified by local application of chemicals; cardiodynamic responses were elicited in nine instances. The activity of six units was modified by isoproterenol after subsequent administration of hexamethonium. These data confirm that intrinsic cardiac neurons possess nicotinic and muscarinic receptors and demonstrate that some intrinsic cardiac neurons also possess @-adrenergic receptors. Furthermore, these data demonstrate that intrinsic cardiac neurons with nicotinic, muscarinic, and ,&adrenergic receptors are involved in cardiac regulation. bethanechol chloride; decentralization; l,l-dimethyl-4-phenylpiperazinium iodide; isoproterenol; parasympathetic; sympathetic IN ADDITION TO the presence of classical postganglionic parasympathetic neurons (13, 24, 27) , recent evidence indicates that efferent adrenergic, afferent, and local circuit neurons exist in mammalian epicardial ganglia (3, 10, 14, 18) , all of which are part of the intrinsic cardiac nervous system (8). Neurons in canine middle cervical and stellate ganglia involved in cardiac regulation can be modified by both nicotinic and P-adrenergic agonists (9). Furthermore, synaptic transmission within canine intrathoracic ganglia can be modulated by padrenergic, muscarinic, and nicotinic antagonists (7). Thus neurons with both cholinergic and adrenergic receptors in extracardiac intrathoracic ganglia are involved in cardiac regulation (7).
Receptor types associated with intrinsic cardiac neurons involved in cardiac regulation are not well established. It is widely accepted that acetylcholine released from parasympathetic efferent preganglionic nerves acts on intrinsic cardiac parasympathetic efferent postganglionic neurons via nicotinic receptors (12, 14, 19, 27) . The relative population of nicotinic-sensitive intrinsic cardiac neurons in a given ganglionated plexus is unknown. Nor is it known whether nicotine can modify efferent adrenergic intrinsic cardiac neurons, whose cardiac augmentor effects can be blocked by a ,&adrenergic antagonist (28) . Muscarinic receptors have also been associated with intrinsic cardiac neurons (2, 20, 22) . However, it is not known whether in situ intrinsic cardiac neurons can be affected by muscarinic agonists. Furthermore, it is not known whether intrinsic cardiac neurons can be affected by /3-adrenergic agonists, as has been found to occur with respect to intrathoracic extrinsic cardiac neurons (9).
In the present study, to evaluate whether the activity generated by intrinsic cardiac neurons can be modified by nicotinic, muscarinic, and P-adrenergic agonists, an experimental model was developed that permitted direct microapplication of these agonists adjacent to spontaneously active in situ epicardial neurons. This study was also undertaken to determine whether these agonists can concomitantly alter neuronal activity as well as cardiodynamics. Furthermore, these experiments were performed before and after acute decentralization of the heart to determine whether such neuronal and cardiac responses are dependent, in part, on connections with other intrathoracic and central neurons.
MATERIALS AND METHODS
Fifteen mongrel dogs of either sex, weighing 17-28 kg, were tranquilized with thiopental sodium (12-15 mg/kg iv) and anesthetized with a-chloralose (100 mg/kg iv). Supplemental doses of cr-chloralose (20-35 mg/kg iv) were administered during the experiments as required. The animal was intubated and respiration maintained with a Bird mark 7 positive-pressure respirator. A bilateral thoracotomy was performed at the fourth intercostal interspace to expose the heart. Right and left vagosympathetic trunks below the middle cervical ganglia were identified, and loose silk ligatures were placed around them so that they could be sectioned later in the experiment to acutely decentralize the intrinsic cardiac nervous system. This procedure disconnected intrinsic cardiac neurons not only from central neurons but also from those in the middle cervical and stellate ganglia.
The ventral pericardium was incised and retracted laterally to expose the ventral right atria1 epicardial fat containing the right atria1 ventral ganglionated plexus (4, 18). A miniature (5 mm diam, 1.5 mm thick) solid-state pressure transducer (model P19D, Konigsberg Instruments, Pasadena, CA) was inserted into the ventrolateral wall of the left ventricle to record regional intramyocardial pressure. Left ventricular chamber pressure was measured via a Cordis no. 7 catheter inserted into the chamber via a femoral artery and connected to a transducer (model 800, Bentley Trantec, Irvine, CA). All data, including a lead II electrocardiogram, were recorded during the experiments on an eight-channel rectilinear recorder (model MT 9500, Astro-Med, West Warwick, RI). The output of the recorder was led to a computer utilizing a 12-bit analog-to-digital converter. Data were stored on ZO-Mb Bernouille disks for later analysis.
Method of local application of neurochemicals.
Pharmacological agents were administered via local microinjection adjacent to the tip of the recording electrode. The microinjection apparatus was a four-barreled glass micropipette (P-5, Activational Values are means k SE; n, no. of responses elicited. We identified a total of 63 intact and 34 decentralized neurons. Neuronal effects of nicotine, DMPP, bethanechol chloride, and isoproterenol were studied in 14, 6, 7 , and 14 dogs, respectively, and are grouped according to whether activity was altered (increased or decreased) or not (nonresponsive) in intact and acutely decentralized states. Significant changes in activity elicited by a -chemical: * P < 0.05; t P < 0.01. Systems, Warren, MI). This pipette was pulled to a fine tip and broken back to an overall tip diameter of 15-20 pm. A tungsten recording microelectrode Frederick Haer, Brunswick, ME) was glued to the glass micropipette, with the tip of the electrode extending ~25 pm beyond the pipette tip. The other ends of the four-barreled micropipette were connected via -30 cm of polyethylene tubing to four 25~1 syringes (model PB 702-1, Hamilton, Reno, NV) held in repeating dispensers (model PB 600-1, Hamilton). This permitted each of the four syringes to deliver 0.5.~1 quantities of a chemical into tissue adjacent to the tip of the recording electrode.
Neuronal recording. Details of the recording procedure have been presented elsewhere (18). In brief, to minimize epicardial motion during each cardiac beat, a circular ring of heavy-gauge wire was gently placed on the epicardial fat of the ventral surface of the right atrium. The tungsten microelectrode-micropipette assembly was mounted on a micromanipulator and placed over the epicardial fat so that the assembly could be slowly advanced into the fat to search for neuronal activity. The indifferent electrode was attached to structures adjacent to the heart. Signals were differentially amplified by a Princeton Applied Research model 113 amplifier that had band-pass filters set at 300 Hz to 10 KHz and an amplification range of lOO500x. The output of this device was further amplified (50-200x) and filtered (bandwidth 100 Hz to 2 kHz) using an optically isolated amplifier (Applied Microelectronics Institute, Halifax, Nova Scotia, Canada). The output of this amplifier was led to a Nicolet model 207 oscilloscope for monitoring of neuronal activity. Signals from the conditioner unit were also led to the recording and storage devices described above.
Under a dissecting microscope, the fat on the ventral surface of the right atrium was explored with the microelectrode at various depths from the surface to regions adjacent to the myocardium. In four animals the recording electrode was also inserted into the subclavian ansae, cervical vagosympathetic trunks, and an intracardiac nerve (the ventral lateral cardiac nerve) in an attempt to record spontaneous activity generated by intrathoracic autonomic axons of passages.
Interventions. The effects of two nicotinic agonists, nicotine (6 x 10e2 M) and l,l-dimethyl-4-phenylpiperazinium iodine (DMPP; 10B2 M), were studied in 18 active loci identified in 15 animals. Effects elicited by the muscarinic agonist bethanechol chloride (10B3 M) were studied in 10 active loci in seven animals. The effects of the @-adrenergic agonist (A)-isoproterenol (2 x 10m2 M) were studied in 16 active loci in 14 animals. Doses of 0.5 ~1 were studied first. If no detectable neuronal response was elicited, larger doses (1, 2, 5, and 10 ~1) were investigated, with 5 min allowed between administrations.
When neuronal responses were elicited, the dose was not increased further. The consistency of neuronal responses elicited by an agonist to repeat application was tested by administrating the same dose of each agonist at least 5 min after application of the agent into each active site if no other chemical had been administered in between. As each agent was applied in random order to a locus, repeat administrations were made, in some instances at least 30 min apart. If identified units in a given locus were not modified by any agent, another active locus was studied. Saline (l-10 ~1) was also administered into active loci from which neurochemicals elicited neuronal responses to test the effects of the injected vehicle. Neuronal activity and cardiac variables were recorded before and immediately after local application of a chemical, as well as subsequently, if activity changes persisted. Between injections 5-10 min were allowed to elapse. The same chemicals were also administered in the same doses into the right coronary artery and superior vena cava in eight animals to determine whether these agents produced neuronal or cardiovascular responses upon entering the systemic circulation.
Acute decentralization was then performed and administrations of the chemicals repeated. In two of these animals, nicotine and isoproterenol were administered after intravenous injection of timolol maleate (1 mg/kg iv) as well as after the subsequent administration of atropine sulfate (1 mg/kg). In another animal, 5 ~1 of timolol(1 pg/pl saline) was injected into an active locus after the effects of regional application of isoproterenol had been tested. Isoproterenol was thereafter reapplied. In four other dogs, isoproterenol was locally administered before and after intravenous injection of the ganglionic blocking agent hexamethonium bromide (10 mg/kg).
To determine whether responses induced by local application of chemicals were due to effects on neuronal somata as opposed to axons of passage, the effects of nicotine or isoproterenol on intrathoracic autonomic nerves were investigated in four additional dogs. This was done by individual injection of nicotine and isoproterenol into the right or left subclavian ansae, the right or left vagosympathetic trunks, or a cardiopulmonary nerve. The lowest dose of nicotine tested was similar to that employed for local injection into epicardial fat, with the highest dose 100 times larger. Isoproterenol was administered in doses similar to those injected into epicardial fat. Furthermore, to determine whether nicotine can affect intrinsic cardiac axons of passage, nicotine was injected into an intrinsic cardiac nerve (the ventral lateral cardiac nerve) while axonal activity and cardiodynamic responses were recorded. In addition, a segment of intrinsic cardiac nerve was removed from the heart and placed in a tissue bath (35°C). A suction electrode was applied to either end of the nerve. Electrical stimuli were delivered to one end of the nerve while evoked activity was recorded from the other end with and without nicotine (4 x 10m2 M) in the perfusate. This was done to determine whether nicotine could modify the propagation of action potentials in intrinsic cardiac nerves.
Data analysis. Periodic motion at the recording site occurred because of cardiac and respiratory dynamics, thereby inducing minor fluctuations in the amplitude of individual action potentials generated by a given unit over time. Fluctuation of the amplitude of an action potential generated by a single unit was found to vary Cl0 PV over several minutes, with action potentials retaining the same shape. Thus action potentials with the same shape and amplitude (+5 rV) were considered to be generated by a single unit. Action potentials with signal-to-noise ratios greater than 3: 1 were analyzed. The frequency of activity (impulses/s) generated by individual neurons was analyzed for 10-s periods during control states. After neurochemical administration, maximal changes in activity were determined during 10-s periods. Associated cardiovascular indexes were measured at that time.
Neuronal data were grouped according to whether activity increased, decreased, or remained unchanged after application of a neurochemical. Heart rate and left ventricular systolic intramyocardial and chamber pressures were measured for 10 consecutive beats. Cardiodynamic changes were classified according to whether recorded variables increased, decreased, or Bethanechol chloride induced changes in neuronal activity. A: during control periods, cardiovascular-related neuronal activity was recorded (heart rate 122 beats/min, IMP 120 mmHg, and LVP 170 mmHg). B: immediately after bethanechol chloride administration, neuronal activity became suppressed. Heart rate decreased as well (107 beats/ min). C: neuronal activity generated by a new unit (large action potential) was recorded shortly thereafter. The unit that was active in control periods was active again (peak heart rate 125 beate/min, IMP 130 mmHg, and LVP 240 mmHg). Ventricular ectopic beats were also induced. Vertical calibration bar beside neuronal activity = 10 NV.
remained unchanged. Spontaneous fluctuations of cardiodynamics were minimal throughout control periods presumably because of the effects of anesthesia. Heart rate variability, for instance, was <5 beats/min, and systolic pressure fluctuations were 4 mmHg during control periods. Thus thresholds for determining whether a change occurred as a result of an intervention were chosen to be larger than these ranges. All data are presented as means f SE. Neuronal and cardiodynamic data obtained before and after each chemical administration were compared using two-tailed Student's t tests for paired data.
Significance was assigned at the 0.05 level.
RESULTS
Neuronal activity. A total of 20 active loci were studied in 15 dogs. Nicotine was tested in 18 loci in 14 dogs, DMPP in 8 loci in 6 dogs, bethanechol chloride in 10 loci in 7 dogs, and isoproterenol in 16 loci in 14 dogs. A total of 55 spontaneously active neurons were identified in these 20 loci ( Table 1 ). The activity of 40 of these neurons was modified by local application of neurochemicals. Eight additional units that had not been active during control periods were recruited after local application of a neurochemical (Table 1) . Each neurochemical modified activity (enhanced or suppressed) in the majority of loci in which it was tested (Table 1) . In a number of instances in which neuronal activity was suppressed, activity was eliminated completely. Spontaneous action potentials were not recorded from intrinsic cardiac nerves or vagosympathetic trunks before and after nicotine application.
Nicotine modified the activity of 25 of 49 identified neurons in 18 loci (Fig. l) , DMPP modified 10 of 19 identified neurons (Table l) , bethanechol chloride modified 17 of 23 identified neurons (Fig. 2) , and isoproterenol modified 25 of 46 identified neurons (Fig. 3A and Table   1 ). The 0.5-and l-p1 doses of neurochemicals usually failed to elicit neuronal response. The 2-, 5-, and lo-p1 doses elicited neuronal response in 43, 100, and 100% of the responsive sites tested, respectively. The average doses used for nicotine, DMPP, bethanechol chloride, and isoproterenol were 4.6 f 0.6,4.2 + 1.0,5.3 + 1.7, and 3.9 + 0.7 ~1, respectively. Qualitatively similar neuronal responses were elicited by repeat application of nicotinic agonists, isoproterenol, and bethanechol chloride in 9,11, and 5 dogs, respectively. In six dogs, nicotine and isoproterenol were reapplied three or four times. Furthermore, similar neuronal responses were induced in intact and decentralized hearts by the same agonists despite the fact 3B ). When saline (l-10 ~1) was injected into an active site, no neuronal response was elicited. Activity generated by some neurons was modified by more than one neurochemical. Among 14 neurons tested with nicotinic, muscarinic, and P-adrenergic agonists, 4 were modified by each of these three agents. Of 31 neurons tested with nicotine and isoproterenol, 21 were modified by both agents. Among these 21 neurons, the activity of 12 units was increased by both nicotine and isoproterenol, and the activity of 4 was decreased by both of these agents. Another five units responded differently to nicotine and isoproterenol. When nicotine and DMPP were applied to the same locus, similar neuronal responses were elicited. After acute decentralization, the number of spontaneously active neurons was reduced compared with that found before decentralization.
A total of 33 units were identified that continued to generate spontaneous activity in eight acutely decentralized preparations. The activities of 11 of these were modified by nicotine (Fig. 4) , 2 by DMPP, 2 by bethanechol chloride, and 12 by isoproterenol ( Fig. 3B and Table 1 ).
After systemic administration of timolol in two decentralized animals, the activities of four units were modified by local application of nicotine but none by isoproterenol. Application of timolol into discrete loci did not modify the capacity of neurons to generate spontaneous activity. However, when this was done, repeat isoproterenol administration failed to elicit any response even though it had done so before local administration of timolol. After atropine administration, spontaneous activity generated by four of six units identified in three animals increased (1.1 t 0.8 to 5.8 t 1.0 impulses/s, P C 0.05). Thereafter, reallocation of bethanechol chloride, but not nicotine, failed to elicit neuronal responses. After systemic injection of hexamethonium, 20 units still generated spontaneous activity. The average basal firing rate of these neurons was 1.1 t 0.3 impulses/s, a rate significantly lower than prehexamethonium values (2.0 t 0.4 impulses/s).
Application
of nicotine did not affect these neurons. However, local application of isoproterenol did modify the activity generated by six of these neurons, with activity either increasing (4 units: 1.3 t 0.4 to 2.8 t 0.5 impulses/s, P c 0.05; Fig. 5 . Local application of nicotine induced increased neuronal activity, heart rate, and cardiac inotropism in an acutely decentralized preparation. A: during control conditions, heart rate was 150 beats/min, systolic IMP was 50 mmHg, and systolic LVP was 125 mmHg. B: after nicotine administration, heart rate was 167 beats/min, IMP was 65 mmHg, and LVP was 155 mmHg. Vertical calibration bar beside neuronal activity = 15 pV. chemicals investigated. Nicotine induced the greatest decrease (from 135 to 48 beats/min; Fig. 1 ) and greatest increase (from 115 to 170 beats/min) in heart rate. When nicotine was injected into the superior vena cava in both of these animals, no neuronal or cardiodynamic changes were elicited. Left ventricular intramyocardial and chamber systolic pressure changes were produced with or without heart rate alterations when chemicals were applied to epicardial fat loci. The greatest increase in left ventricular intramyocardial (from 150 to 220 mmHg) and chamber (from 145 to 200 mmHg) systolic pressures occurred after local application of isoproterenol. Cardiodynamic responses were always associated with changes in neuronal activity.
After acute decentralization, cardiodynamic responses were induced by injecting agents into 9 of 17 previously affective loci (Table 2 ). The neuronal and cardiodynamic responses induced before and after decentralization were similar in five of these instances. In contrast, in three cases in which cardiodynamic and neuronal responses were elicited before decentralization by nicotine and isoproterenol, cardiovascular responses were no longer elicited when these chemicals were reapplied to the same loci after decentralization.
Despite elimination of cardiodynamic effects, neuronal responses were similar before and after decentralization in these three instances (Fig. 3) . After acute decentralization, the greatest increase in heart rate (from 126 to 160 beats/min) was produced by isoproterenol and the greatest decrease in heart rate (from 150 to 100 beats/min) by nicotine. The greatest increase in left ventricular intramyocardial (from 90 to 180 mmHg) and chamber (from 140 to 160 mmHg) systolic pressures decentralization.
was elicited bY nicotine
After systemic injection of timolol in one animal, local application of nicotine failed to elicit the tachycardia and increased ventricular force that previously had been produced when nicotine was administered to the same site. In another animal, after atropine administration, heart rate and ventricular pressures were augmented by local application of nicotine. However, these responses were no longer elicited by nicotine after the subsequent systemic administration of timolol. Cardiodynamic responses were not elicited by neurochemicals in the presence of atropine and timolol.
Neuronal activity and cardiodynamics were not altered when saline (10 ~1) was injected into active loci. No significant cardiodynamic responses were observed when 5 ~1 of nicotine was injected into the superior vena cava of eight animals; when 10 ~1 of nicotine was administered into the superior vena cava, moderate cardiovascular changes were elicited in a few instances. Moderate car- into the right coronary artery in every animal tested. When bethanechol chloride (10 ~1) was administered into the superior vena cava or right coronary artery, no cardiovascular changes were elicited. When large doses of nicotine (lo-100 ~1) were injected into the subclavian ansae or vagosympathetic trunks of four dogs, no cardiodynamic responses were induced. When bethanechol chloride and isoproterenol were administered individually into subclavian ansae or vagosympathetic trunks, no cardiodynamic changes were induced. When an intrinsic cardiac nerve was exposed in vitro to concentrations of nicotine similar to those tested in vivo, no spontaneous action potentials were recorded. Furthermore, the capacity of intrinsic cardiac axons to conduct action potentials generated by electrical stimulation was not modified after exposure to nicotine.
The results of the present study demonstrate that nicotinic, muscarinic, and ,&adrenergic agonists can modify the spontaneous activity generated by canine intrinsic cardiac neurons. In association with these activity changes, cardiodynamics can also be modified. Because some neurocardiac responses were produced after acute decentralization, it appears that modulation of the intrinsic cardiac nervous system by these agonists can be achieved independent of connections to higher levels of the nervous system.
The spontaneous action potentials identified in loci of the ventral right atria1 ganglionated plexus presumably were not recorded from axons of passage because action potentials generated by intrinsic cardiac axons could not be recorded with certitude, implying that the methods employed are not useful for nerve recording. Similarly, it is difficult to discern axonal potentials generated by axons in a subclavian ansa, vagosympathetic complex, or Values are means t SE; n, no. of responses elicited. Data derived from both neurally intact and decentralized states were grouped according to whether cardiac indexes increased (positive) or decreased (negative) after application of each of the 4 agents. * P < 0.05. cardiopulmonary nerve (5). In contrast, action potentials with signal-to-noise ratios greater than 3:l have been associated with spontaneous activity generated by neuronal somata of intrathoracic autonomic ganglia (5), including those on the heart (3,10,18). Thus the action potential recorded in the present experiments presumably did not originate from intrinsic cardiac axons but rather from neuronal somata.
The absence of neuronal response after local administration of saline into active loci indicates that the vehicle was not responsible for neuronal responses elicited. When varying doses of nicotine or isoproterenol were injected into a subclavian ansa or vagosympathetic complexes, cardiodynamics were not altered. Furthermore, the capacity of intrinsic cardiac nerves to conduct action potentials was not modified by nicotine. These data indicate that when spontaneous activity was modified by local application of nicotine or the other chemicals, this was not due to effects elicited on axons of passage. Rather, it appears that such responses were due to modulation of neuronal somata or dendrites, although the possibility of affecting presynaptic terminals cannot be excluded.
When neurochemicals such as nicotine (10 ~1) are injected into a coronary artery, pronounced cardiovascular effects can be initiated -10 s later. Because neurochemicals injected into the coronary circulation can affect intrinsic cardiac neurons in many areas of the heart, extrinsic cardiac neurons, and adrenal medullary cells, this method of administration was not considered to be appropriate for assessing the regulatory role of intrinsic cardiac neurons on the heart. In contrast, when neurochemicals are applied in microliter quantities into epicardial fat, the chemicals apparently do not leak out of the fat in sufficient quantities to modify distant tissues, including neurons, in a detectable fashion. Thus the method chosen for neurochemical administration, i.e., into active loci in cardiac ganglionated plexi, was chosen because it avoided the problem of the chemical entering the coronary circulation in sufficient quantities to directly affect distant intrinsic cardiac neurons, efferent autonomic nerve terminals in cardiac tissue, extrinsic cardiac neurons, or the adrenal medulla.
Nicotinic agonists. Nicotine modified the activity generated by 51% of the neurons tested. Of these, 76% responded with increased activity (Table 1) . Nicotinic receptors have been associated with efferent postganglionic parasympathetic neurons in amphibian (21) and mammalian (13, 14) intrinsic cardiac ganglia. The presence of such receptors presumably accounts for the fact that intrinsic cardiac neurons can be excited by local application of nicotine (26, 27) . Similarly, DMPP, another nicotinic receptor agonist (15, 16) , modified neuronal activity of 53% of tested neurons (Table 1) . That -50% of the identified neurons displayed activity that was increased by nicotine may reflect receptor heterogeneity of intrinsic cardiac neurons, i.e., a substantial number of such neurons do not contain nicotinic receptors (7, 8) . Activation of intrinsic cardiac parasympathetic neurons would induce negative chronotropic and inotropic cardiac responses (13, 14, 24) . In keeping with this, in the present experiments, when intrinsic cardiac neurons were excited by nicotinic agonists, pronounced decreases in heart rate did occur ( Fig. 1 and Table 2 ). In some instances local application of nicotine suppressed spontaneous intrinsic cardiac neuronal activity, as can occur in isolated preparations (26) . Perhaps such effects account for the fact that local application of nicotinic agonists resulted in decreases as well as increases in spontaneous activity generated by some intrinsic cardiac neurons.
Adrenergic neurons have been identified in mammalian intrinsic cardiac ganglia by anatomic techniques (12, 17, 23, 25) . Physiological evidence indicates that efferent adrenergic neurons exist in the mammalian intrinsic cardiac nervous system, neurons that are involved in cardiac regulation (11, 14) . However, it is unclear how many of these neurons are involved in cardiac regulation, what receptors they contain, and whether they continue to function after decentralization.
The present experiments demonstrate that a population of intrinsic cardiac neurons exists that, when modified by nicotine, can induce cardiac augmentation (Table 2 ). The incidence of cardiac augmentor response elicited by local application of nicotine was greater than depressor responses. The doses of nicotine (~5 ~1) studied that produced cardiodynamic changes failed to elicit cardiovascular responses when administered into the superior vena cava. Nicotine, when applied in similar quantities to inactive loci, elicited no cardiovascular responses. Thus it appears that the cardiac augmentation so elicited was not the result of nicotine entering the circulation from an injection site in sufficient quantities to affect distant sympathetic neurons or efferent sympathetic postganglionic nerve terminals remote from the injection sites.
After acute decentralization, about half of the neurons that previously had been spontaneously active still generated activity (Table 1 ). Thus input from higher centers was not necessary for some intrinsic cardiac neurons to generate activity. Nicotine or DMPP, administered locally after decentralization, continued to affect neuronal activity (Fig. 4) and elicited cardiac responses from a number of sites tested. When cardiac augmentor responses were elicited, these were presumed to be due to direct or indirect activation of intrinsic cardiac efferent adrenergic neurons because cardiac but not neuronal responses were eliminated after timolol administration.
In some of these instances considerable cardiac augmentation was induced (Table 2 and Fig. 4 ), implying that a substantial population of nicotine-sensitive adrenergic neurons exists on the canine heart that are involved in cardiac regulation. or inhibition (hyperpolarization) via Ml and M2 muscarinic receptors, respectively (2). The fact that intrinsic cardiac neuronal activity was modified by local application of the nonspecific muscarinic agonist bethanechol chloride (Fig. 2 and Table l), as well as after intravenous atropine administration, supports the contention that muscarinic synapses are present in the intrinsic cardiac neuron system.
In association with neuronal activity changes, concomitant alterations in cardiodynamics were elicited when bethanechol chloride was studied (Fig. 3 and Table  2 ). Bethanechol chloride can exert minor direct depressor effects on cardiac myocytes (19) . Despite this, when bethanechol chloride was injected systemically in higher doses than those used for local application, cardiovascular responses were not elicited. These data indicate that cardiodynamic responses elicited by local administration of bethanechol chloride were not due to leakage of the agent into the circulation. Rather, they appear to have been mediated by intrinsic cardiac neurons with muscarinic receptors. In one animal in which bethanechol chloride modified neuronal activity, a concomitant ventricular arrhythmia was induced (Fig. 2) . These data indicate that intrinsic cardiac neurons sensitive to muscarinic agonists not only may regulate heart rate and contractile force but also may be involved in the genesis of cardiac dysrhythmias.
fl-Adrenergic agonist. Local administration of isoproterenol induced alteration of neuronal activity in about half of the active loci studied (Table 1) . Changes in neuronal activity were accompanied by cardiodynamic responses when isoproterenol was injected into 5 of 12 loci before decentralization (Table 2) . Anatomic (12, 23) and physiological (1, 26) evidence supports the existence of intrinsic cardiac neurons with adrenergic receptors. Data from the present study demonstrate, for the first time, that activity of some mammalian intrinsic cardiac neurons can be modified by ,8-adrenergic agonists. After local or systemic administration of the P-adrenergic blocker timolol, isoproterenol no longer modified neuronal activity even though nicotinic and muscarinic agonists did. Modification of neuronal activity by isoproterenol was frequently associated with cardiac augmentation (Fig. 3 and Table 2 ). Presumably such effects were due to the direct or indirect activation of efferent sympathetic cardiac neurons, thereby eliciting cardiac augmentation. These results suggest that intrinsic cardiac adrenergic neurons contain P-adrenergic receptors in addition to nicotinic ones. Cardiac responses produced by the local application of isoproterenol were not likely due to chemical leakage into the circulation in sufficient quantities to directly affect cardiac myocytes because the majority of isoproterenol injections failed to elicit cardiodynamic changes even though neuronal activity changed. The fact that it is unlikely that isoproterenol directly affected cardiac myocytes is further supported by the fact that, in a number of instances, cardiac responses were no longer elicited by isoproterenol after decentralization, even though similar neuronal responses were elicited in both states (Fig. 3) .
Neuronal responses induced by isoproterenol remained unchanged after acute decentralization in over half of the cases (Table 1 ). These data indicate that intrinsic cardiac neurons can be modified by P-agonist even when such neurons are disconnected from other intrathoracic and central neurons. Such modulation can occur independent of nicotinic transmission because some neuronal responses elicited by isoproterenol persisted after hexamethonium administration (Fig. 5) . These results confirm the existence of non-nicotine-sensitive intrinsic cardiac neurons, as discussed above. In a number of instances alteration in neuronal activity elicited by isoproterenol was accompanied by cardiac augmentation either before or after acute decentralization (Table 2 ). However, in other instances, associated cardiodynamic effects observed before decentralization were no longer elicited by isoproterenol after decentralization even though similar neuronal responses were elicited in the two states (Fig. 3) . It is possible that in these latter instances neurons with ,&adrenergic receptors projected axons centrally to involve central reflex-mediated activation of efferent cardiac sympathetic neurons, thereby accounting for the elimination of induced cardiac effects after decentralization.
A decrease in heart rate was elicited after local administration of isoproterenol in one decentralized preparation ( Table 2 )) suggesting that some intrinsic cardiac neurons with P-adrenergic receptors may exert inhibitory effects on sinoatrial node function.
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Spontaneous activity generated by about half of the identified intrinsic cardiac units was directly or indirectly affected by more than one neurochemical, implying that a diversity of inputs may occur to a single intrinsic cardiac neuron. In other words, some intrinsic cardiac neurons apparently received multiple presynaptic inputs that can be mediated by different neurotransmitters.
This contention is supported by the finding that a mammalian intrinsic cardiac neuron can be innervated by several axons in a single nerve (25, 26) or different axons arising from different nerves (26) . The diversity of activity patterns generated by individual neurons in response to cholinergic or p-adrenergic agonists indicates that cholinergic and P-adrenergic pathways may converge on individual intrinsic cardiac neurons. Because neuronal responses elicited by isoproterenol sometimes were altered after nicotinic blockade, elimination of nicotinic synaptic input may affect some neuronal responses elicited by ,&ad-renergic synaptic inputs. With respect to units that were not modified by any of the agents tested, this could have been because some intrinsic cardiac neurons do not possess receptors for these agents. 
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The dissociation between neuronal activity and cardiac effects that frequently occurred presumably was due to the fact that the number of efferent cardiac neurons directly or indirectly modified by an agent frequently were insufficient to elicit detectable cardiac responses. In addition, neurons innervating the atria, right ventricle, or coronary vessels may have been affected, and because the dynamic changes in these structures were not assessed, such effects would have gone undetected. Nicotinic, muscarinic, and ,&adrenergic agonists can modify the activity of in situ intrinsic cardiac neurons. Intrinsic cardiac neurons with nicotinic, muscarinic, or P-adrenergic receptors can participate in cardiac regulation, even after acute decentralization.
These data indicate that intrinsic cardiac neurons with choline@ and adrenergic receptors, acting either alone or in concert with other intrathoracic and central neurons, regulate the heart. 17.
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